1-3 of 3
Giada Ingoglia
Close
Sort by
Journal Articles

The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease

Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda, Anna Flace, Giada Ingoglia, Raphael M. Buzzi, Cédric Doucerain, Paul W. Buehler, Dominik J. Schaer, Franz Dürrenberger, Vania Manolova
Journal: Blood
Blood (2022) 140 (7): 769–781.
https://doi.org/10.1182/blood.2021014716
Published: 2022
Includes: Multimedia, Supplemental data
Journal Articles

Hemopexin therapy reverts heme-induced proinflammatory phenotypic switching of macrophages in a mouse model of sickle cell disease

Francesca Vinchi, Milene Costa da Silva, Giada Ingoglia, Sara Petrillo, Nathan Brinkman, Adrian Zuercher, Adelheid Cerwenka, Emanuela Tolosano, Martina U. Muckenthaler
Journal: Blood
Blood (2016) 127 (4): 473–486.
https://doi.org/10.1182/blood-2015-08-663245
Published: 2016
Includes: Supplemental data
Journal Articles

The Heme Scavenger Hemopexin Reverts Heme-Driven Pro-Inflammatory Phenotypic Switching of Macrophages in Sickle Cell Disease

Francesca Vinchi, PhD, Milene Costa da Silva, PhDstudent, Giada Ingoglia, PhDstudent, Sara Petrillo, PhDstudent, Nathan Brinkman, Adrian Zuercher, Adelheid Cerwenka, PhD, Emanuela Tolosano, PhD, Martina U. Muckenthaler, PhD
Journal: Blood
Blood (2015) 126 (23): 2205.
https://doi.org/10.1182/blood.V126.23.2205.2205
Published: 2015